Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://www.ncbi.nlm.nih.gov/pubmed/29950163
http://dx.doi.org/10.1186/s12941-018-0281-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://www.ncbi.nlm.nih.gov/pubmed/29950163
http://dx.doi.org/10.1186/s12941-018-0281-x

Ejemplares similares